Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/26552
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Özmen, Süay | - |
dc.date.accessioned | 2022-05-20T07:34:20Z | - |
dc.date.available | 2022-05-20T07:34:20Z | - |
dc.date.issued | 2012-06 | - |
dc.identifier.citation | Özmen, S. ve Özmen, Ö. A. (2012). "Is local ointment or cauterization more effective in childhood recurrent epistaxis". International Journal of Pediatric Otorhinolaryngology, 76(6), 783-786. | en_US |
dc.identifier.issn | 0165-5876 | - |
dc.identifier.issn | 1872-8464 | - |
dc.identifier.uri | https://doi.org/10.1016/j.ijporl.2012.02.040 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0165587612001334?via%3Dihub | - |
dc.identifier.uri | http://hdl.handle.net/11452/26552 | - |
dc.description.abstract | Objectives: To compare the efficacy of nasal antiseptic ointment and silver nitrate cautery in the treatment of children with recurrent epistaxis. Methods: In this prospective and randomized study, a hundred children with recurrent epistaxis were assigned into two groups. In group 1, patients underwent silver nitrate cauterization, in group 2 patients were treated with nasal antiseptic ointment (oxytetracycline hydrochloride-polymyxin B sulfate); and both groups were followed for 3 months. All of the patients were investigated for allergy with skin prick test. Results: The ages of patients were similar in both groups (group 1:9.2 +/- 2.7; group 2:8.2 +/- 2.2; p = 0.069). Thirty-eight percent of the patients in group 1 and 52% of the patients in group 2 had epistaxis in the three months follow-up. The difference between groups was not significant (p = 0.159). Thirteen (26%) of the patients in group 1 and 12(24%) of the patients in group 2 were found to have allergic symptoms and positive prick test. The rate of allergy was similar in both groups (p = 0.817). Conclusion: Nasal antiseptic ointment and silver nitrate cauterization were found to have similar outcomes in the treatment of recurrent epistaxis. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Ireland | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Otorhinolaryngology | en_US |
dc.subject | Pediatrics | en_US |
dc.subject | Recurrent epistaxis | en_US |
dc.subject | Nasal antiseptic ointment | en_US |
dc.subject | Silver nitrate cauterization | en_US |
dc.subject | Randomized controlled-trial | en_US |
dc.subject | Silver-nitrate cautery | en_US |
dc.subject | Single-blind | en_US |
dc.subject | Management | en_US |
dc.subject | Anterior | en_US |
dc.subject | Cream | en_US |
dc.subject.mesh | Administration, intranasal | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Anti-Infective agents, local | en_US |
dc.subject.mesh | Cautery | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, preschool | en_US |
dc.subject.mesh | Epistaxis | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-up studies | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Ointments | en_US |
dc.subject.mesh | Prospective studies | en_US |
dc.subject.mesh | Recurrence | en_US |
dc.subject.mesh | Risk assessment | en_US |
dc.subject.mesh | Severity of illness index | en_US |
dc.subject.mesh | Silver nitrate | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.title | Is local ointment or cauterization more effective in childhood recurrent epistaxis | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000305367300005 | tr_TR |
dc.identifier.scopus | 2-s2.0-84861460063 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kulak Burun Boğaz Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-9698-0546 | tr_TR |
dc.identifier.startpage | 783 | tr_TR |
dc.identifier.endpage | 786 | tr_TR |
dc.identifier.volume | 76 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | International Journal of Pediatric Otorhinolaryngology | en_US |
dc.contributor.buuauthor | Özmen, Ömer Afşin | - |
dc.contributor.researcherid | A-1452-2019 | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 22409966 | tr_TR |
dc.subject.wos | Otorhinolaryngology | en_US |
dc.subject.wos | Pediatrics | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q2 (Otorhinolaryngology) | en_US |
dc.wos.quartile | Q3 (Pediatrics) | en_US |
dc.contributor.scopusid | 55407733900 | tr_TR |
dc.subject.scopus | Epistaxis; Cauterization; Nose Septum | en_US |
dc.subject.emtree | Oxytetracycline plus polymyxin b | en_US |
dc.subject.emtree | Silver nitrate | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Chemical cauterization | en_US |
dc.subject.emtree | Chemotherapy | en_US |
dc.subject.emtree | Child | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Drug efficacy | en_US |
dc.subject.emtree | Drug hypersensitivity | en_US |
dc.subject.emtree | Epistaxis | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Ointment | en_US |
dc.subject.emtree | Outcome assessment | en_US |
dc.subject.emtree | Prick test | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Prospective study | en_US |
dc.subject.emtree | Randomized controlled trial | en_US |
dc.subject.emtree | Recurrent disease | en_US |
dc.subject.emtree | Recurrent epistaxis | en_US |
dc.subject.emtree | Risk reduction | en_US |
dc.subject.emtree | School child | en_US |
dc.subject.emtree | Treatment duration | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.